Scientists have identified the precise molecular trigger behind a rare blood-clotting disorder linked to certain adenovirus-based COVID-19 vaccines and, in rare cases, natural adenovirus infection. Researchers led by Flinders University, working with international collaborators, have clarified how a rare blood clotting disorder can develop after certain COVID-19 adenovirus-based vaccines or following a natural adenovirus infection. […]Health,COVID-19,Flinders University,Immunology,Vaccine#Study #Finally #Uncovers #Molecular #Trigger #Rare #COVID #Vaccine #Blood #Clots1772410774
